25 XP   0   0   10

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
Buy, Hold or Sell?

Let's analyse Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd together

PenkeI guess you are interested in Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

I send you an email if I find something interesting about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

Quick analysis of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (30 sec.)










What can you expect buying and holding a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
92.5%

What is your share worth?

Current worth
¥-0.18
Expected worth in 1 year
¥-0.62
How sure are you?
42.5%

+ What do you gain per year?

Total Gains per Share
¥-0.39
Return On Investment
-4.4%

For what price can you sell your share?

Current Price per Share
¥8.78
Expected price per share
¥7.27 - ¥10.08
How sure are you?
50%

1. Valuation of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.78

Intrinsic Value Per Share

¥4.18 - ¥5.14

Total Value Per Share

¥4.00 - ¥4.95

2. Growth of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (5 min.)




Is Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?-$3m$6.7m-$8.1m-556.5%

How much money is Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.2m-$1.5m-$685.4k-30.7%
Net Profit Margin-56.0%-36.8%--

How much money comes from the company's main activities?

3. Financial Health of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (5 min.)




What can you expect buying and holding a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd? (5 min.)

Welcome investor! Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's management wants to use your money to grow the business. In return you get a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

What can you expect buying and holding a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd?

First you should know what it really means to hold a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is ¥8.78. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥-0.18. Based on the TTM, the Book Value Change Per Share is ¥-0.11 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.00-0.1%-0.01-0.2%-0.01-0.1%-0.01-0.1%0.000.0%
Usd Book Value Change Per Share0.000.0%-0.02-0.2%-0.01-0.1%-0.01-0.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%-0.01-0.2%-0.01-0.1%-0.01-0.1%0.000.0%
Usd Price Per Share1.34-1.21-1.17-1.44-1.77-
Price to Earnings Ratio-73.00--31.74--27.40--732.62--310.56-
Price-to-Total Gains Ratio-721.71--241.59--122.55--182.40-480.91-
Price to Book Ratio-52.72--7.26-22.58-11.65-17.22-
Price-to-Total Gains Ratio-721.71--241.59--122.55--182.40-480.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.212518
Number of shares824
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.02-0.01
Usd Total Gains Per Share-0.01-0.01
Gains per Quarter (824 shares)-11.00-6.16
Gains per Year (824 shares)-43.99-24.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16-50-546-31-35
212-100-9813-62-60
318-150-14219-93-85
424-200-18626-124-110
529-249-23032-155-135
635-299-27439-187-160
741-349-31845-218-185
847-399-36252-249-210
953-449-40658-280-235
1059-499-45065-311-260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%11.019.010.027.5%39.019.029.044.8%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%3.017.00.015.0%11.029.00.027.5%36.051.00.041.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.00.03.092.5%68.00.019.078.2%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%17.023.00.042.5%49.038.00.056.3%

Fundamentals of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

About Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces and sells medicines and related health care products, including tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, pills, soft capsules, tablets, granules, and other health foods. It is also involved in the sale of menthol and peppermint oil raw materials, Chinese medicine formulas, Chinese medicine pieces, fresh herbs, etc.; and provision of professional medical services, such as valet decoction and distribution, as well as Chinese medicine diagnosis and treatment services. In addition, the company engages in the software development, remote health management, commercial complex management, food, Internet information businesses, etc. The company was founded in 1958 and is headquartered in Hangzhou, China.

Fundamental data was last updated by Penke on 2024-04-17 09:29:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of -11.5% means that ¥-0.11 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is -11.5%. The company is making a huge loss. -2
  • The TTM is -56.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-11.5%TTM-56.0%+44.5%
TTM-56.0%YOY-36.8%-19.2%
TTM-56.0%5Y-25.6%-30.5%
5Y-25.6%10Y-9.7%-15.8%
1.1.2. Return on Assets

Shows how efficient Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • -1.2% Return on Assets means that Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd generated ¥-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is -1.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM-5.6%+4.4%
TTM-5.6%YOY-3.0%-2.6%
TTM-5.6%5Y-2.3%-3.3%
5Y-2.3%10Y-0.7%-1.6%
1.1.3. Return on Equity

Shows how efficient Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • 0.0% Return on Equity means Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-41.9%+41.9%
TTM-5Y-13.3%+13.3%
5Y-13.3%10Y-4.6%-8.8%

1.2. Operating Efficiency of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is operating .

  • Measures how much profit Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-4.2%+4.2%
TTM-4.2%YOY-29.2%+25.0%
TTM-4.2%5Y-7.6%+3.4%
5Y-7.6%10Y-3.5%-4.1%
1.2.2. Operating Ratio

Measures how efficient Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.84 means that the operating costs are ¥1.84 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 1.844. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.930. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.844TTM1.930-0.085
TTM1.930YOY2.031-0.101
TTM1.9305Y1.788+0.142
5Y1.78810Y1.229+0.559

1.3. Liquidity of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 0.62 means the company has ¥0.62 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.618. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.538. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.618TTM0.538+0.080
TTM0.538YOY0.679-0.141
TTM0.5385Y0.791-0.253
5Y0.79110Y0.432+0.359
1.3.2. Quick Ratio

Measures if Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.10 means the company can pay off ¥0.10 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.101. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.136. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.101TTM0.136-0.036
TTM0.136YOY0.378-0.242
TTM0.1365Y0.343-0.207
5Y0.34310Y0.293+0.051

1.4. Solvency of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 1.07 means that Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd assets are financed with 106.6% credit (debt) and the remaining percentage (100% - 106.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 1.066. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.036. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.066TTM1.036+0.029
TTM1.036YOY0.873+0.163
TTM1.0365Y0.853+0.183
5Y0.85310Y0.796+0.057
1.4.2. Debt to Equity Ratio

Measures if Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 0.0% means that company has ¥0.00 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY12.463-12.463
TTM-5Y5.706-5.706
5Y5.70610Y4.597+1.109

2. Market Valuation of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd generates.

  • Above 15 is considered overpriced but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of -73.00 means the investor is paying ¥-73.00 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The EOD is -66.214. Based on the earnings, the company is expensive. -2
  • The MRQ is -73.002. Based on the earnings, the company is expensive. -2
  • The TTM is -31.745. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-66.214MRQ-73.002+6.787
MRQ-73.002TTM-31.745-41.257
TTM-31.745YOY-27.402-4.343
TTM-31.7455Y-732.617+700.873
5Y-732.61710Y-310.557-422.061
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The EOD is -697.109. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -768.567. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -217.062. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-697.109MRQ-768.567+71.458
MRQ-768.567TTM-217.062-551.505
TTM-217.062YOY65.021-282.082
TTM-217.0625Y-28.237-188.825
5Y-28.23710Y-18.852-9.384
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of -52.72 means the investor is paying ¥-52.72 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The EOD is -47.815. Based on the equity, the company is expensive. -2
  • The MRQ is -52.717. Based on the equity, the company is expensive. -2
  • The TTM is -7.264. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-47.815MRQ-52.717+4.901
MRQ-52.717TTM-7.264-45.453
TTM-7.264YOY22.576-29.840
TTM-7.2645Y11.654-18.918
5Y11.65410Y17.220-5.566
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.026-0.110+317%-0.094+259%-0.068+160%-0.024-10%
Book Value Per Share---0.184-0.087-52%0.399-146%0.583-131%0.644-129%
Current Ratio--0.6180.538+15%0.679-9%0.791-22%0.432+43%
Debt To Asset Ratio--1.0661.036+3%0.873+22%0.853+25%0.796+34%
Debt To Equity Ratio----0%12.463-100%5.706-100%4.597-100%
Dividend Per Share--0.0130.013-1%0.013-2%0.014-9%0.021-38%
Eps---0.033-0.097+192%-0.092+178%-0.056+69%-0.015-55%
Free Cash Flow Per Share---0.003-0.077+2335%-0.089+2734%0.000-819%-0.038+1101%
Free Cash Flow To Equity Per Share---0.003-0.081+2470%-0.039+1142%-0.008+145%-0.018+473%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.750+33%
Intrinsic Value_10Y_max--5.136--------
Intrinsic Value_10Y_min--4.179--------
Intrinsic Value_1Y_max---0.121--------
Intrinsic Value_1Y_min---0.119--------
Intrinsic Value_3Y_max--0.122--------
Intrinsic Value_3Y_min--0.106--------
Intrinsic Value_5Y_max--0.948--------
Intrinsic Value_5Y_min--0.838--------
Market Cap1069219620.000-10%1178820720.0001070132962.500+10%1031163682.500+14%1271981655.000-7%1557279407.250-24%
Net Profit Margin---0.115-0.560+388%-0.368+220%-0.256+123%-0.097-15%
Operating Margin----0.0420%-0.2920%-0.0760%-0.0350%
Operating Ratio--1.8441.930-4%2.031-9%1.788+3%1.229+50%
Pb Ratio-47.815+9%-52.717-7.264-86%22.576-334%11.654-552%17.220-406%
Pe Ratio-66.214+9%-73.002-31.745-57%-27.402-62%-732.617+904%-310.557+325%
Price Per Share8.780-10%9.6808.788+10%8.468+14%10.445-7%12.788-24%
Price To Free Cash Flow Ratio-697.109+9%-768.567-217.062-72%65.021-1282%-28.237-96%-18.852-98%
Price To Total Gains Ratio-654.609+9%-721.711-241.588-67%-122.550-83%-182.404-75%480.915-250%
Quick Ratio--0.1010.136-26%0.378-73%0.343-71%0.293-66%
Return On Assets---0.012-0.056+373%-0.030+150%-0.023+96%-0.007-39%
Return On Equity----0%-0.4190%-0.1330%-0.0460%
Total Gains Per Share---0.013-0.097+620%-0.081+505%-0.054+304%-0.003-79%
Usd Book Value---3088123.234-1468669.934-52%6705100.605-146%9804675.985-131%10834348.283-129%
Usd Book Value Change Per Share---0.004-0.015+317%-0.013+259%-0.009+160%-0.003-10%
Usd Book Value Per Share---0.025-0.012-52%0.055-146%0.081-131%0.089-129%
Usd Dividend Per Share--0.0020.002-1%0.002-2%0.002-9%0.003-38%
Usd Eps---0.005-0.013+192%-0.013+178%-0.008+69%-0.002-55%
Usd Free Cash Flow---52954.103-1289324.530+2335%-1500685.930+2734%7362.893-819%-445136.804+741%
Usd Free Cash Flow Per Share--0.000-0.011+2335%-0.012+2734%0.000-819%-0.005+1101%
Usd Free Cash Flow To Equity Per Share--0.000-0.011+2470%-0.005+1142%-0.001+145%-0.002+473%
Usd Market Cap147659229.522-10%162795141.432147785362.121+10%142403704.553+14%175660666.556-7%215060286.141-24%
Usd Price Per Share1.213-10%1.3371.214+10%1.169+14%1.442-7%1.766-24%
Usd Profit---557503.854-2236229.954+301%-1550817.506+178%-1080605.667+94%-319708.985-43%
Usd Revenue--4854667.9244029814.792+20%4334255.940+12%6333796.058-23%6312422.285-23%
Usd Total Gains Per Share---0.002-0.013+620%-0.011+505%-0.007+304%0.000-79%
 EOD+2 -6MRQTTM+23 -9YOY+23 -105Y+15 -1810Y+11 -23

3.2. Fundamental Score

Let's check the fundamental score of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-66.214
Price to Book Ratio (EOD)Between0-1-47.815
Net Profit Margin (MRQ)Greater than0-0.115
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.101
Current Ratio (MRQ)Greater than10.618
Debt to Asset Ratio (MRQ)Less than11.066
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.012
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.879
Ma 20Greater thanMa 508.821
Ma 50Greater thanMa 1008.910
Ma 100Greater thanMa 2009.979
OpenGreater thanClose8.780
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Interest Income  217292-108231113-178-65



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets340,443
Total Liabilities362,804
Total Stockholder Equity-42,085
 As reported
Total Liabilities 362,804
Total Stockholder Equity+ -42,085
Total Assets = 340,443

Assets

Total Assets340,443
Total Current Assets181,058
Long-term Assets159,384
Total Current Assets
Cash And Cash Equivalents 100,946
Net Receivables 29,512
Inventory 41,849
Other Current Assets 302
Total Current Assets  (as reported)181,058
Total Current Assets  (calculated)172,609
+/- 8,449
Long-term Assets
Property Plant Equipment 149,754
Goodwill 2,199
Intangible Assets 5,254
Long-term Assets  (as reported)159,384
Long-term Assets  (calculated)157,206
+/- 2,178

Liabilities & Shareholders' Equity

Total Current Liabilities292,771
Long-term Liabilities70,033
Total Stockholder Equity-42,085
Total Current Liabilities
Short Long Term Debt 102,500
Accounts payable 39,705
Other Current Liabilities 433
Total Current Liabilities  (as reported)292,771
Total Current Liabilities  (calculated)142,638
+/- 150,133
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt6,656
Long-term Liabilities Other 1,430
Long-term Liabilities  (as reported)70,033
Long-term Liabilities  (calculated)8,086
+/- 61,946
Total Stockholder Equity
Total Stockholder Equity (as reported)-42,085
Total Stockholder Equity (calculated)0
+/- 42,085
Other
Capital Stock121,779
Common Stock Shares Outstanding 121,779
Net Debt 1,554
Net Invested Capital 60,415
Net Working Capital -111,713
Property Plant and Equipment Gross 149,754



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
403,864
405,881
373,001
408,746
412,448
420,957
378,173
373,530
388,445
375,370
358,473
346,517
361,557
354,192
343,986
357,853
369,790
370,239
350,088
372,708
365,901
361,826
372,251
352,475
386,584
395,495
438,083
414,089
439,148
406,910
401,898
369,082
360,215
329,461
315,364
328,273
310,766
313,202
307,424
319,794
320,771
311,094
298,735
357,836
335,341
332,960
335,896
295,925
311,655
323,445
324,886
324,584
320,825
337,343
289,712
288,339
277,141
268,978
267,020
280,382
302,072
286,234
297,308
306,193
284,139
293,489
308,178
431,406
482,066
428,915
439,161
464,073
479,185
524,756
533,105
540,843
529,704
523,761
518,985
442,510
440,791
431,144
418,885
402,649
390,947
373,435
348,939
299,840
284,210
256,606
340,443
340,443256,606284,210299,840348,939373,435390,947402,649418,885431,144440,791442,510518,985523,761529,704540,843533,105524,756479,185464,073439,161428,915482,066431,406308,178293,489284,139306,193297,308286,234302,072280,382267,020268,978277,141288,339289,712337,343320,825324,584324,886323,445311,655295,925335,896332,960335,341357,836298,735311,094320,771319,794307,424313,202310,766328,273315,364329,461360,215369,082401,898406,910439,148414,089438,083395,495386,584352,475372,251361,826365,901372,708350,088370,239369,790357,853343,986354,192361,557346,517358,473375,370388,445373,530378,173420,957412,448408,746373,001405,881403,864
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
149,376
132,526
217,227
233,159
178,523
183,525
235,623
221,037
213,238
206,844
222,925
225,387
215,229
202,964
186,075
178,582
165,273
144,896
124,133
112,452
92,890
181,058
181,05892,890112,452124,133144,896165,273178,582186,075202,964215,229225,387222,925206,844213,238221,037235,623183,525178,523233,159217,227132,526149,376000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,249
10,609
86,805
65,215
24,211
13,814
25,696
19,890
12,989
5,750
7,574
3,119
33,856
41,031
22,291
13,526
9,163
20,820
42,392
27,108
6,823
100,946
100,9466,82327,10842,39220,8209,16313,52622,29141,03133,8563,1197,5745,75012,98919,89025,69613,81424,21165,21586,80510,60914,249000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
90,912
90,628
137,806
92,247
106,196
125,084
147,989
85,920
99,244
96,151
142,861
140,456
153,921
158,194
157,858
156,731
172,252
174,548
165,423
161,212
173,574
173,275
90,768
108,942
174,898
124,423
143,488
75,360
105,319
109,669
115,025
134,469
141,851
89,543
83,331
62,096
76,931
64,023
66,759
66,412
93,256
72,951
75,853
107,576
108,309
110,158
106,401
53,537
83,686
64,204
66,063
60,552
58,306
65,098
47,121
46,390
36,958
32,539
36,843
25,736
28,465
24,840
25,618
38,725
35,911
35,967
39,801
56,241
74,646
68,917
57,224
59,341
71,333
60,167
62,942
98,210
91,787
83,291
76,658
141,837
152,849
123,980
100,914
106,748
107,373
97,983
63,971
30,806
30,769
33,463
29,512
29,51233,46330,76930,80663,97197,983107,373106,748100,914123,980152,849141,83776,65883,29191,78798,21062,94260,16771,33359,34157,22468,91774,64656,24139,80135,96735,91138,72525,61824,84028,46525,73636,84332,53936,95846,39047,12165,09858,30660,55266,06364,20483,68653,537106,401110,158108,309107,57675,85372,95193,25666,41266,75964,02376,93162,09683,33189,543141,851134,469115,025109,669105,31975,360143,488124,423174,898108,94290,768173,275173,574161,212165,423174,548172,252156,731157,858158,194153,921140,456142,86196,15199,24485,920147,989125,084106,19692,247137,80690,62890,912
       Other Current Assets 
10,931
1,390
2,205
3,476
3,186
3,435
2,208
3,224
5,014
3,783
6,117
5,898
8,342
6,701
6,080
5,960
7,141
6,224
2,378
2,159
1,287
1,221
13,009
11,273
8,759
41,270
39,119
112,970
94,423
62,985
78,430
26,500
28,620
17,482
17,738
20,971
17,467
17,391
8,281
6,612
3,688
4,236
2,582
7,527
9,768
12,806
7,431
10,448
6,787
10,534
7,934
7,808
18,367
5,747
288
3,700
1,202
2,545
2,375
2,894
3,087
2,528
1,693
2,163
3,007
2,279
3,331
53,200
45,975
2,690
3,257
1,705
1,798
73
1,124
55,752
61,522
56,262
61,289
6,002
6,681
3,731
4,671
4,679
5,301
3,855
2,805
381
886
5,540
302
3025,5408863812,8053,8555,3014,6794,6713,7316,6816,00261,28956,26261,52255,7521,124731,7981,7053,2572,69045,97553,2003,3312,2793,0072,1631,6932,5283,0872,8942,3752,5451,2023,7002885,74718,3677,8087,93410,5346,78710,4487,43112,8069,7687,5272,5824,2363,6886,6128,28117,39117,46720,97117,73817,48228,62026,50078,43062,98594,423112,97039,11941,2708,75911,27313,0091,2211,2872,1592,3786,2247,1415,9606,0806,7018,3425,8986,1173,7835,0143,2242,2083,4353,1863,4762,2051,39010,931
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
246,026
346,232
349,581
357,735
360,785
310,523
312,141
219,586
215,403
215,915
215,921
216,573
212,365
208,163
204,043
175,707
171,758
163,716
159,384
159,384163,716171,758175,707204,043208,163212,365216,573215,921215,915215,403219,586312,141310,523360,785357,735349,581346,232246,026000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
110,741
115,106
115,934
115,102
113,767
115,069
120,987
123,702
125,512
126,118
126,842
106,716
108,362
107,673
106,309
105,664
105,573
109,722
108,944
113,599
108,653
112,798
109,922
113,362
93,727
108,696
125,482
89,539
102,227
112,689
81,667
92,317
79,474
88,832
81,519
98,304
80,651
90,686
83,209
95,822
85,748
97,891
86,495
96,508
85,896
95,805
85,900
95,878
85,419
96,548
85,084
102,635
97,766
106,560
108,540
116,616
117,165
116,381
118,385
135,044
136,684
119,705
124,497
126,689
133,920
139,388
144,819
145,894
145,534
144,347
171,950
168,622
167,061
158,424
159,943
211,644
215,322
221,056
223,507
200,120
196,359
197,527
197,495
199,815
196,334
193,122
189,692
164,937
161,333
153,577
149,754
149,754153,577161,333164,937189,692193,122196,334199,815197,495197,527196,359200,120223,507221,056215,322211,644159,943158,424167,061168,622171,950144,347145,534145,894144,819139,388133,920126,689124,497119,705136,684135,044118,385116,381117,165116,616108,540106,56097,766102,63585,08496,54885,41995,87885,90095,80585,89696,50886,49597,89185,74895,82283,20990,68680,65198,30481,51988,83279,47492,31781,667112,689102,22789,539125,482108,69693,727113,362109,922112,798108,653113,599108,944109,722105,573105,664106,309107,673108,362106,716126,842126,118125,512123,702120,987115,069113,767115,102115,934115,106110,741
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,024
21,024
21,024
21,024
21,024
21,024
21,024
21,024
21,024
21,024
21,024
21,024
5,644
5,644
5,644
5,644
3,315
3,315
2,724
2,724
2,199
2,199
2,199
2,199
2,1992,1992,1992,1992,7242,7243,3153,3155,6445,6445,6445,64421,02421,02421,02421,02421,02421,02421,02421,02421,02421,02421,02421,0240000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,747
1,747
1,747
1,747
1,747
1,747
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,7471,7471,7471,7471,7471,747000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
6,589
12,458
12,342
12,508
12,112
11,717
11,334
9,583
9,217
8,852
10,186
8,118
7,752
7,386
7,020
9,132
8,640
3,021
7,657
1,974
6,875
1,722
6,557
1,507
6,273
1,251
5,950
995
7,383
739
10,376
963
13,042
653
26,202
429
11,566
393
11,177
379
11,029
354
10,876
329
10,723
304
10,570
279
10,416
254
11,724
229
10,110
7,521
7,458
6,640
6,583
8,792
8,721
8,651
8,581
8,511
8,440
8,370
8,301
8,230
7,938
28,895
72,924
51,556
51,220
50,854
50,522
50,191
52,313
47,989
47,673
47,357
47,041
5,679
5,641
5,602
5,563
5,525
5,486
5,447
5,408
5,370
5,331
5,292
5,254
5,2545,2925,3315,3705,4085,4475,4865,5255,5635,6025,6415,67947,04147,35747,67347,98952,31350,19150,52250,85451,22051,55672,92428,8957,9388,2308,3018,3708,4408,5118,5818,6518,7218,7926,5836,6407,4587,52110,11022911,72425410,41627910,57030410,72332910,87635411,02937911,17739311,56642926,20265313,04296310,3767397,3839955,9501,2516,2731,5076,5571,7226,8751,9747,6573,0218,6409,1327,0207,3867,7528,11810,1868,8529,2179,58311,33411,71712,11212,50812,34212,4586,589
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,747
112,140
112,140
54,140
54,140
0
223,507
0
0
0
0
0
0
0
0
0
0
0
0
000000000000223,507054,14054,140112,140112,1402,747000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
156,608
154,596
120,992
157,113
158,972
166,014
122,117
120,324
133,788
118,691
102,122
103,878
117,461
110,037
99,880
105,493
115,824
114,221
114,018
133,323
124,954
120,413
130,130
116,035
147,109
117,644
165,219
131,160
151,425
138,417
135,309
128,784
119,587
114,839
111,486
140,532
122,787
124,334
119,817
165,659
165,129
156,049
142,661
175,000
158,737
173,680
181,600
200,252
213,375
227,137
232,157
226,408
222,729
245,620
201,942
200,177
192,465
189,907
195,166
217,626
244,168
231,762
235,114
240,010
221,138
234,736
233,554
334,177
349,512
283,937
295,158
372,515
390,589
431,209
437,524
401,146
390,565
386,770
382,305
349,178
350,811
344,908
341,954
338,091
333,421
332,330
317,918
295,360
289,704
275,769
362,804
362,804275,769289,704295,360317,918332,330333,421338,091341,954344,908350,811349,178382,305386,770390,565401,146437,524431,209390,589372,515295,158283,937349,512334,177233,554234,736221,138240,010235,114231,762244,168217,626195,166189,907192,465200,177201,942245,620222,729226,408232,157227,137213,375200,252181,600173,680158,737175,000142,661156,049165,129165,659119,817124,334122,787140,532111,486114,839119,587128,784135,309138,417151,425131,160165,219117,644147,109116,035130,130120,413124,954133,323114,018114,221115,824105,49399,880110,037117,461103,878102,122118,691133,788120,324122,117166,014158,972157,113120,992154,596156,608
   > Total Current Liabilities 
156,508
154,596
120,993
157,113
158,972
166,014
122,117
120,325
133,788
118,691
102,122
103,478
117,461
109,237
99,081
104,694
115,024
113,421
113,217
132,523
124,154
118,614
129,331
115,236
146,309
112,786
164,419
128,081
148,478
136,094
133,352
127,984
118,787
114,039
110,685
139,732
121,987
123,534
119,017
164,859
164,329
155,249
141,861
174,200
157,937
172,880
180,800
199,452
212,575
226,337
203,040
196,808
194,805
205,051
148,096
162,842
157,645
155,580
160,195
183,128
209,885
197,695
201,262
201,757
182,307
146,206
145,326
230,498
246,160
187,546
198,373
314,735
328,156
220,605
216,845
205,175
183,133
189,478
207,254
251,887
255,789
253,163
253,485
251,151
249,759
251,202
239,902
221,221
216,642
204,748
292,771
292,771204,748216,642221,221239,902251,202249,759251,151253,485253,163255,789251,887207,254189,478183,133205,175216,845220,605328,156314,735198,373187,546246,160230,498145,326146,206182,307201,757201,262197,695209,885183,128160,195155,580157,645162,842148,096205,051194,805196,808203,040226,337212,575199,452180,800172,880157,937174,200141,861155,249164,329164,859119,017123,534121,987139,732110,685114,039118,787127,984133,352136,094148,478128,081164,419112,786146,309115,236129,331118,614124,154132,523113,217113,421115,024104,69499,081109,237117,461103,478102,122118,691133,788120,325122,117166,014158,972157,113120,993154,596156,508
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,000
71,700
56,000
38,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000038,00056,00071,70033,00000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,000
71,700
56,000
38,000
38,000
48,000
54,800
82,781
113,387
112,787
102,082
106,607
106,746
106,007
104,621
104,495
104,643
104,504
104,579
102,500
102,500104,579104,504104,643104,495104,621106,007106,746106,607102,082112,787113,38782,78154,80048,00038,00038,00056,00071,70033,00000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
4,089
7,341
12,282
11,836
18,574
11,540
17,253
12,825
12,533
11,372
12,905
12,964
14,491
12,835
12,768
11,226
12,841
22,395
15,090
15,988
16,156
14,915
17,086
15,688
19,782
17,479
25,378
19,774
18,225
19,437
9,460
23,240
22,639
26,982
15,682
28,595
12,035
19,332
8,213
13,559
6,163
11,826
3,563
23,798
14,467
25,286
13,627
35,732
44,615
50,907
57,474
49,327
42,784
27,252
19,940
25,454
31,032
28,493
40,249
29,331
55,673
25,035
32,783
18,886
21,874
17,533
21,788
31,548
50,687
36,596
39,508
38,710
67,348
43,878
60,238
56,100
64,542
55,772
58,978
53,463
74,974
57,295
77,054
66,029
66,659
42,082
54,655
47,223
46,724
28,420
39,705
39,70528,42046,72447,22354,65542,08266,65966,02977,05457,29574,97453,46358,97855,77264,54256,10060,23843,87867,34838,71039,50836,59650,68731,54821,78817,53321,87418,88632,78325,03555,67329,33140,24928,49331,03225,45419,94027,25242,78449,32757,47450,90744,61535,73213,62725,28614,46723,7983,56311,8266,16313,5598,21319,33212,03528,59515,68226,98222,63923,2409,46019,43718,22519,77425,37817,47919,78215,68817,08614,91516,15615,98815,09022,39512,84111,22612,76812,83514,49112,96412,90511,37212,53312,82517,25311,54018,57411,83612,2827,3414,089
       Other Current Liabilities 
19,519
22,749
23,205
32,877
31,998
29,074
30,464
32,100
32,355
29,906
28,707
32,004
29,970
27,302
27,913
27,068
29,783
23,626
28,727
27,135
27,598
21,299
28,845
25,648
54,427
36,807
78,591
48,807
75,903
68,657
65,492
44,394
31,098
19,057
35,003
33,137
35,952
24,702
20,805
56,327
57,189
42,427
37,311
46,420
43,927
51,608
54,136
41,724
46,007
65,199
37,566
45,481
46,020
88,800
36,157
43,388
30,613
38,087
30,445
66,798
44,712
56,160
41,479
54,371
40,432
39,673
42,538
112,450
142,973
40,241
80,597
98,572
165,062
54,440
114,629
32,531
63,372
26,186
58,749
72,246
61,540
75,404
62,332
70,461
69,996
87,337
72,821
490
439
55,761
433
43355,76143949072,82187,33769,99670,46162,33275,40461,54072,24658,74926,18663,37232,531114,62954,440165,06298,57280,59740,241142,973112,45042,53839,67340,43254,37141,47956,16044,71266,79830,44538,08730,61343,38836,15788,80046,02045,48137,56665,19946,00741,72454,13651,60843,92746,42037,31142,42757,18956,32720,80524,70235,95233,13735,00319,05731,09844,39465,49268,65775,90348,80778,59136,80754,42725,64828,84521,29927,59827,13528,72723,62629,78327,06827,91327,30229,97032,00428,70729,90632,35532,10030,46429,07431,99832,87723,20522,74919,519
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
62,433
210,604
220,679
206,565
204,421
197,292
175,051
97,291
95,023
91,746
88,469
86,939
83,662
81,128
78,015
74,139
73,062
71,021
70,033
70,03371,02173,06274,13978,01581,12883,66286,93988,46991,74695,02397,291175,051197,292204,421206,565220,679210,60462,433000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
400
0
800
799
799
800
800
801
800
800
1,799
799
799
800
777
800
799
800
800
801
800
800
800
801
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
29,117
29,600
27,924
40,569
53,846
37,335
34,820
34,327
34,971
34,498
34,283
34,067
33,852
38,253
38,831
38,530
38,228
57,680
57,353
50,391
50,785
51,280
50,933
179,104
170,679
153,793
151,650
147,292
144,051
97,291
95,023
91,746
88,469
82,388
79,018
76,165
73,260
0
0
64,377
0
064,3770073,26076,16579,01882,38888,46991,74695,02397,291144,051147,292151,650153,793170,679179,10450,93351,28050,78550,39157,35357,68038,22838,53038,83138,25333,85234,06734,28334,49834,97134,32734,82037,33553,84640,56927,92429,60029,1178008008008008008008008008008008008008008008008018008008008018008007998007778007997991,799800800801800800799799800040000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,245
6,074
4,308
4,091
4,795
4,577
6,852
6,540
7,549
7,031
6,888
6,505
5,888
5,964
5,935
5,246
4,886
4,234
0
0
1,924
0
01,924004,2344,8865,2465,9355,9645,8886,5056,8887,0317,5496,5406,8524,5774,7954,0914,3086,0746,245000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
229,856
226,633
225,441
224,372
225,399
226,567
227,222
223,551
224,638
226,054
225,543
212,837
214,112
213,901
213,770
221,141
222,291
224,081
204,123
207,488
208,697
208,935
209,352
206,277
208,607
220,374
214,295
228,074
232,568
241,733
240,188
224,838
225,341
199,541
188,972
172,595
172,739
173,231
171,182
140,691
141,622
141,053
141,358
168,014
160,896
142,215
138,070
79,172
81,960
80,146
76,324
81,280
81,903
80,649
81,134
81,650
78,267
73,156
66,202
57,193
52,248
48,941
56,718
58,970
55,877
51,742
67,509
67,112
87,388
99,151
96,845
58,230
54,398
58,387
59,907
103,997
103,858
103,623
102,470
72,843
69,774
66,693
57,714
45,184
39,358
24,589
15,597
-14,627
-23,682
-38,048
-42,085
-42,085-38,048-23,682-14,62715,59724,58939,35845,18457,71466,69369,77472,843102,470103,623103,858103,99759,90758,38754,39858,23096,84599,15187,38867,11267,50951,74255,87758,97056,71848,94152,24857,19366,20273,15678,26781,65081,13480,64981,90381,28076,32480,14681,96079,172138,070142,215160,896168,014141,358141,053141,622140,691171,182173,231172,739172,595188,972199,541225,341224,838240,188241,733232,568228,074214,295220,374208,607206,277209,352208,935208,697207,488204,123224,081222,291221,141213,770213,901214,112212,837225,543226,054224,638223,551227,222226,567225,399224,372225,441226,633229,856
   Common Stock
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
0
0
121,779
0
0121,77900121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779
   Retained Earnings 
37,376
33,840
32,649
31,224
32,250
33,419
34,074
30,252
31,339
32,755
32,244
19,395
20,670
20,459
20,328
23,884
25,034
26,824
6,866
7,215
8,424
8,662
9,079
7,602
9,860
13,413
15,619
21,517
26,411
35,963
35,518
25,597
26,100
300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-74,125
-76,432
-115,047
-143,060
-139,071
-137,551
-67,909
-67,934
-70,310
-72,025
-111,832
-114,901
-117,983
-126,962
-141,634
-147,460
-162,889
-171,881
-233,375
-242,431
-232,615
-260,833
-260,833-232,615-242,431-233,375-171,881-162,889-147,460-141,634-126,962-117,983-114,901-111,832-72,025-70,310-67,934-67,909-137,551-139,071-143,060-115,047-76,432-74,1250000000000000000000000000000000000030026,10025,59735,51835,96326,41121,51715,61913,4139,8607,6029,0798,6628,4247,2156,86626,82425,03423,88420,32820,45920,67019,39532,24432,75531,33930,25234,07433,41932,25031,22432,64933,84037,376
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
656
656
656
656
0
0
0
0
0
0
0
0
0
0
0
0
000000000000656656656656000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue116,722
Cost of Revenue-89,234
Gross Profit27,48827,488
 
Operating Income (+$)
Gross Profit27,488
Operating Expense-134,209
Operating Income-17,487-106,721
 
Operating Expense (+$)
Research Development1,946
Selling General Administrative9,247
Selling And Marketing Expenses-
Operating Expense134,20911,193
 
Net Interest Income (+$)
Interest Income58
Interest Expense-7,136
Other Finance Cost-309
Net Interest Income-7,387
 
Pretax Income (+$)
Operating Income-17,487
Net Interest Income-7,387
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-65,429-17,487
EBIT - interestExpense = -7,136
-64,771
-57,635
Interest Expense7,136
Earnings Before Interest and Taxes (EBIT)--58,293
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-65,429
Tax Provision-835
Net Income From Continuing Ops-66,264-66,264
Net Income-64,771
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-7,387
 

Technical Analysis of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The general trend of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.65 < 10.02 < 10.08.

The bearish price targets are: 7.95 > 7.55 > 7.27.

Tweet this
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current macd is -0.13960829.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current adx is 24.80.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current sar is 7.634496.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current rsi is 49.88. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Relative Strength Index (RSI) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Stochastic Oscillator ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current cci is -3.19422601.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Commodity Channel Index (CCI) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current cmo is 6.73247507.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current willr is -35.26315789.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Williams %R ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current atr is 0.35728616.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Average True Range (ATR) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current obv is 37,870,489.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily On-Balance Volume (OBV) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current mfi is 34.50.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Money Flow Index (MFI) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.879
Ma 20Greater thanMa 508.821
Ma 50Greater thanMa 1008.910
Ma 100Greater thanMa 2009.979
OpenGreater thanClose8.780
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

I send you an email if I find something interesting about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

Receive notifications about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd in your mailbox!